Curaleaf Holdings (CURLF) Change in Taxes (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Taxes of $12.7 million for Q4 2024, up 149.71% year-on-year from $5.1 million in Q1 2024, and up 183.25% on a QoQ basis from $4.5 million in Q3 2024.
Curaleaf Holdings (CURLF) Change in Taxes (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Change in Taxes for 6 consecutive years, with $12.7 million the latest figure, recorded in Q4 2024.
- Quarterly Change in Taxes rose 149.71% year-over-year to $12.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.5 million (up 102.88% YoY) and the FY2024 annual result came in at -$174.6 million, down 463.83% from the prior year.
- Change in Taxes rose to $12.7 million in Q4 2024 per CURLF's latest filing, from $4.5 million in the prior quarter.
- Over the last five years, Change in Taxes for CURLF reached as high as $143.3 million in Q2 2022 and fell as low as -$121.6 million in Q3 2022.
- A 5-year average of $6.1 million and a median of $10.6 million in 2020 frame the typical range for Change in Taxes.
- The largest YoY upside for Change in Taxes was 668.12% in 2021 against a maximum downside of 666.45% in 2021.
- Year by year, Change in Taxes stood at $47.8 million in 2020, then sank by 151.38% to -$24.5 million in 2021, then slumped by 135.09% to -$57.7 million in 2022, then jumped by 55.61% to -$25.6 million in 2023, then soared by 149.71% to $12.7 million in 2024.
- According to Business Quant data, Change in Taxes over the past three periods registered $12.7 million, $4.5 million, and -$25.6 million for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.73 Mn |
| Dec 31, 2024 | 12.73 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Dec 31, 2022 | -57.70 Mn |
| Dec 31, 2022 | -57.70 Mn |
| Sep 30, 2022 | -121.60 Mn |
| Sep 30, 2022 | -121.60 Mn |
| Jun 30, 2022 | 143.26 Mn |
| Jun 30, 2022 | 143.26 Mn |
| Mar 31, 2022 | 43.86 Mn |
| Mar 31, 2022 | 43.86 Mn |
| Dec 31, 2021 | -24.54 Mn |
| Dec 31, 2021 | -24.54 Mn |
| Sep 30, 2021 | 67.15 Mn |
| Sep 30, 2021 | 67.15 Mn |